chemokine receptor inhibitors (Sosei)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namechemokine receptor inhibitors (Sosei)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 6 inhibitorsC-C chemokine receptor type 4 antagonistsC-C chemokine receptor type 7 antagonists +[4] 
TargetsC-C chemokine receptor type 6C-C chemokine receptor type 7C-C chemokine receptor type 4 +[4] 
Therapy Area/IndicationsHypersensitivityArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNxera Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsHypersensitivityArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A